
As drug denials increase, experts discuss the importance of optimizing data to keep up with these changes and implementing artificial intelligence (AI) to reduce the burden on providers and ensure patient access to care and treatment.
Michael Gao, MD, a physician-turned-health-tech entrepreneur, has been addressing barriers to care with AI-driven solutions. As the cofounder of SmarterDx, Gao and his team have developed technology that streamlines the appeals process, helping hospitals secure the reimbursements they are entitled to while reducing administrative burden.
As drug denials increase, experts discuss the importance of optimizing data to keep up with these changes and implementing artificial intelligence (AI) to reduce the burden on providers and ensure patient access to care and treatment.
259 Prospect Plains Rd, Bldg H
Monroe, NJ 08831
© 2025 MJH Life Sciences®
All rights reserved.